EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025

Alejandro Martín-Toribio iD, Inés Inchausti-Moya, Marina Toquero-Asensio, Sonia García-Díaz, Javier Sanchez-Martinez, Carla Rodriguez-Crespo, Silvia Galindo-Carretero, Raquel Iglesia-Aparicio, Celia Lopez-Gonzalo, Ana Antón-Contreras, Silvia Rojo-Rello, Marta Dominguez-Gil und 4 weitere

Influenza and Other Respiratory Viruses · 2026-07 · 20 (7)

DOI: 10.1111/irv.70288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 26.06.2026. Verfasst von Alejandro Martín-Toribio und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Influenza Centre, Valladolid, Spain. Hauptthemen laut MEDLINE: Dibenzothiepins, Triazines, Amino Acid Substitution, Pyridones. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science, Universities and Innovation, Universidad CEU San Pablo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza causes 650,000 deaths, 3–5 million hospitalizations, and 1 billion cases worldwide each year. There is a limited repertoire of antivirals available to tackle this burden, highlighting the risk of developing resistance to current drugs. An effort to develop new influenza antivirals has been made, leading to the approval of baloxavir. Some mutations leading to reduced susceptibility to baloxavir have been reported, but information about their epidemiology is scarce. Thus, we aim to evaluate the prevalence of substitutions in the polymerase acidic (PA) subunit associated with baloxavir susceptibility over 16 epidemiological seasons in Europe.

Methods

We evaluated 87,266 sequences collected from 2009 to 2025 in Europe, annotated the mutations, and identified all known amino acid substitutions related to changes in baloxavir susceptibility to assess their prevalence.

Results

A total of 149 (0.2%) sequences with at least one substitution were identified, 81 (0.09%) exhibiting reduced susceptibility. Overall, 17 different substitutions were detected, located both inside and outside baloxavir binding site. The number of substitutions detected ranged from 0 to 15 per season, with E23K, E23R, K34R, A36V, I38F, I38L, and E120D emerging after baloxavir approval in Europe. Double and triple concurrent substitutions were also identified.

Conclusion

While the prevalence of sequences with substitutions that alter baloxavir susceptibility remains stable, the number of circulating substitutions increases over time. This implies the emergence of amino acid substitutions that did not circulate before and the concurrence of double and triple substitutions that might synergize their individual effects. These results highlight the need for virological surveillance and novel antiviral treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DibenzothiepinsTriazinesAmino Acid SubstitutionPyridonesAntiviral AgentsMorpholinesDrug Resistance, ViralRNA-Dependent RNA PolymeraseInfluenza, HumanViral ProteinsThiepinsHumansEuropeMutation

Stichwörter der Autor:innen

antiviral resistancebaloxavirantiviral drugsinfluenza

Substanzen

baloxavirDibenzothiepinsTriazinesPyridonesAntiviral AgentsMorpholinesRNA-Dependent RNA PolymerasePA protein, influenza virusesViral ProteinsThiepins

Autor:innen und Institutionen

  • National Influenza Centre, Valladolid, Spain.
  • Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, Soria, Spain.
  • Microbiology Area, Faculty of Medicine, University of Valladolid, Spain.
  • Microbiology Section, Departamento de Ciencias, Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
  • Institute of Applied Molecular Medicine Nemesio Diez (IMMA-ND), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
  • Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

ORCID-Profile: Alejandro Martín-Toribio, Marta Hernández, Jose M Eiros

Förderung

  • Ministry of Science, Universities and Innovation
  • Universidad CEU San Pablo

Zitieren

APA

Martín-Toribio, A., Inchausti-Moya, I., Toquero-Asensio, M., García-Díaz, S., Sanchez-Martinez, J., Rodriguez-Crespo, C., Galindo-Carretero, S., Iglesia-Aparicio, R., Lopez-Gonzalo, C., Antón-Contreras, A., Rojo-Rello, S., Dominguez-Gil, M., Hernández, M., Eiros, J. M., Nistal-Villan, E., & Sanz-Muñoz, I. (2026). A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025. Influenza and Other Respiratory Viruses, 20(7). https://doi.org/10.1111/irv.70288

Vancouver

Martín-Toribio A, Inchausti-Moya I, Toquero-Asensio M, García-Díaz S, Sanchez-Martinez J, Rodriguez-Crespo C, et al. A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025. Influenza and Other Respiratory Viruses. 2026;20(7). doi:10.1111/irv.70288

BibTeX
@article{MartnToribio2026,
  author = {Martín-Toribio, Alejandro and Inchausti-Moya, Inés and Toquero-Asensio, Marina and García-Díaz, Sonia and Sanchez-Martinez, Javier and Rodriguez-Crespo, Carla and Galindo-Carretero, Silvia and Iglesia-Aparicio, Raquel and Lopez-Gonzalo, Celia and Antón-Contreras, Ana and Rojo-Rello, Silvia and Dominguez-Gil, Marta and Hernández, Marta and Eiros, Jose M and Nistal-Villan, Estanislao and Sanz-Muñoz, Iván},
  title = {A Sequence‐Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.1111/irv.70288}
}
Kostenlos starten →